Nisa Investment Advisors
VOR icon

Nisa Investment Advisors’s Vor Biopharma VOR Stock Holding History

Nisa Investment Advisors’s Portfolio VOR Stock Details VOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2
Closed -$107 – 2978
2024
Q1 		$107 Hold
2
– – ﹤0.01% 2710
2023
Q4 		$101 Hold
2
– – ﹤0.01% 2614
2023
Q3 		$95 Sell
2
-193
-99% -$10.5K ﹤0.01% 2737
2023
Q2 		$12.1K Hold
195
– – ﹤0.01% 2227
2023
Q1 		$21K Hold
195
– – ﹤0.01% 2000
2022
Q4 		$26K Hold
195
– – ﹤0.01% 1983
2022
Q3 		$19K Hold
195
– – ﹤0.01% 2069
2022
Q2 		$19K Buy
+195
New +$20K ﹤0.01% 2064

Other funds holding VOR

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Nisa Investment Advisors's VOR Position: Q2 2024 in Review

Nisa Investment Advisors sold out of Vor Biopharma (VOR) in Q2 2024, closing a stake of 2 shares — an estimated $107 sold.

Nisa Investment Advisors first reported a position in VOR in Q2 2022 and held it in 8 quarters. The position peaked at $26K in Q4 2022. 71 funds tracked by Wall St. Rank hold VOR as of Q2 2024.

  • Nisa Investment Advisors reported no remaining Vor Biopharma position as of Q2 2024 after selling out during the quarter.
  • Nisa Investment Advisors sold 2 Vor Biopharma shares in Q2 2024, an estimated $107.
  • Nisa Investment Advisors first reported a position in Vor Biopharma in Q2 2022 and held it in 8 quarters.
  • Nisa Investment Advisors's Vor Biopharma position peaked at $26K in Q4 2022.
  • 71 funds tracked by Wall St. Rank held Vor Biopharma as of Q2 2024.

Based on Nisa Investment Advisors's 13F filing for Q2 2024, filed 19 Jul 2024.